Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene

Cell

Volumn 82, Issue 6, 1995, Pages 981-988

  Goga, Andrei ^a   McLaughlin, Jami ^a   Afar, Daniel E H ^a   Saffran, Douglas C ^a   Witte, Owen N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; INTERLEUKIN 7; PROTEIN TYROSINE KINASE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; ENZYME ACTIVATION; FIBROBLAST CULTURE; GENE EXPRESSION; HEMATOPOIETIC CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE; POINT MUTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALIA;

EID: 0029087475     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(95)90277-5     Document Type: Article

References (45)

1. Differential complementation of Bcr-Abl point mutants with c-Myc
2. Signaling by ABL oncogenes through cyclin D1
3. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
4. Human Sosl: a guanine nucleotide exchange factor for Ras that binds to GRB2
5. bcr/abl protein
6. bcr/abl gene of the Philadelphia chromosome
7. Transplantation of normal and leukemic human bone marrow into immune-deficient mice: development of animal models for human hematopoiesis
8. bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice
9. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases
10. Efficient transplantation of BCR/ABL-induced chronic myelogenous leukemialike syndrome in mice
11. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity
12. Ras gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes
13. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL
14. Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene
15. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity
16. The molecular genetics of Philadelphia chromosome-positive leukemias
17. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling
18. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products
19. Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells
20. Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo
21. Alternative forms of the BCR-ABL oncogene have quantitatively different potencies forstimulation of immature lymphoid cells
22. Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcrlabl fusion proteins
23. BCR first exon sequences specifically activate Bcr/Abl tyrosine kinase oncogene of Philadelphia chromosome positive human leukemias
24. Identification of CRKL as the constituitively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells
25. The novel activation of ABL by fusion to an ets-related gene, TEL
26. SH2 and SH3 domains in signal transduction
27. Production of high titer helper-free retroviruses by transient transfection
28. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
29. SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor-independence
30. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein
31. Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway
32. Interaction of SHC with GRB2 regulates association of GRB2 with mSOS
33. Control of hemopoiesis by a bone marrow stromal cell clone: lipopolysaccharideand interleukin-1-inducible production of colony-stimulating factors
34. The viral and cellular forms of the Abelson (abl) oncogene
35. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins
36. Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4
37. Chronic myelomonocytic leukemia: Tel-a-kinase what Ets all about
38. Genetic requirement for ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene
39. The function of GRB2 in linking the insulin recptor to ras signaling pathways
40. Catalytic specificity of protein-tyrosine kinases is critical for selective Signalling
41. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
42. Tyrosine phosphorylation of CRKL in Philadelphia' leukemia
43. Abelson virus-infected cells can exhibit restricted in vitro growth and low oncogenic potential
44. Long-term culture of B lymphocytes and their precursors from murine bone marrow
45. Hyperexpression of interleukin-7 is not necessary or sufficient for transformation of a pre-B lymphoid cell line